MCID: INF038
MIFTS: 77

Influenza

Categories: Genetic diseases, Infectious diseases

Aliases & Classifications for Influenza

MalaCards integrated aliases for Influenza:

Name: Influenza 12 72 28 51 3 3 14 69
Flu 12 40 3 59
Influenza with Non-Respiratory Manifestation 12
Influenza with Other Manifestations Nos 12
Influenza with Other Manifestations 12
Influenza, Human 41

Classifications:



External Ids:

Disease Ontology 12 DOID:8469
ICD10 32 J11.1
ICD9CM 34 487
MeSH 41 D007251
NCIt 46 C53482
UMLS 69 C0021400

Summaries for Influenza

MedlinePlus : 40 Flu is a respiratory infection caused by a number of viruses. The viruses pass through the air and enter your body through your nose or mouth. Between 5% and 20% of people in the U.S. get the flu each year. The flu can be serious or even deadly for elderly people, newborn babies, and people with certain chronic illnesses. Symptoms of the flu come on suddenly and are worse than those of the common cold. They may include Body or muscle aches Chills Cough Fever Headache Sore throat Is it a cold or the flu? Colds rarely cause a fever or headaches. Flu almost never causes an upset stomach. And "stomach flu" isn't really flu at all, but gastroenteritis. Most people with the flu recover on their own without medical care. People with mild cases of the flu should stay home and avoid contact with others, except to get medical care. If you get the flu, your health care provider may prescribe medicine to help your body fight the infection and lessen symptoms. The main way to keep from getting the flu is to get a yearly flu vaccine. Good hygiene, including hand washing, can also help. NIH: National Institute of Allergy and Infectious Diseases

MalaCards based summary : Influenza, also known as flu, is related to avian influenza and viral infectious disease, and has symptoms including chills, fever and sore throat. An important gene associated with Influenza is IFITM3 (Interferon Induced Transmembrane Protein 3), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Tequin and Heparin have been mentioned in the context of this disorder. Affiliated tissues include respiratory tract, testes and lung, and related phenotypes are Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers and Decreased influenza A H1N1 (A/WSN/33) virus numbers

Disease Ontology : 12 A viral infectious disease that results_in infection, located in respiratory tract, has material basis in Influenzavirus A, has material basis in Influenzavirus B, or has material basis in Influenzavirus C, which are transmitted_by droplet spread of oronasal secretions during coughing, sneezing, or talking from an infected person. It is a highly contagious disease that affects birds and mammals and has symptom chills, has symptom fever, has symptom sore throat, has symptom runny nose, has symptom muscle pains, has symptom severe headache, has symptom cough, and has symptom weakness.

CDC : 3 Flu Report

PubMed Health : 59
About flu: People often talk about having the flu (influenza) when they come down with a cold. Yet the course of these two illnesses is very different and they also typically have different signs and symptoms.Colds are much more common than the flu. They also start quite slowly, while the viruses that cause the flu strike quickly and cause more severe symptoms – even in people who are otherwise quite healthy. The flu makes you feel very ill quite suddenly. Colds don't usually cause any serious harm, and are often over within a week, with or without treatment. It is a good idea to see a doctor if you have the flu, and it may take some time before you fully recover.But colds and the flu do have one thing in common: The treatment for both focuses on relieving the symptoms. The only medicines that target the flu viruses directly can at most reduce the time you are ill. But a number of things can be done to avoid infection in the first place.

Wikipedia : 72 Influenza, commonly known as \"the flu\", is an infectious disease caused by an influenza virus.... more...

Related Diseases for Influenza

Diseases in the Influenza family:

Influenza, Severe

Diseases related to Influenza via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 522)
# Related Disease Score Top Affiliating Genes
1 avian influenza 34.3 DDX58 FURIN IRF7
2 viral infectious disease 30.2 DDX58 IRF7 ISG15 MX1
3 stomatitis 30.1 DDX58 IFITM3 RSAD2
4 dengue virus 29.7 DDX58 IFITM3 RSAD2
5 west nile virus 29.7 DDX58 IFITM3 MX1 RSAD2
6 rift valley fever 29.6 IFITM3 MX1
7 swine influenza 12.7
8 haemophilus influenzae 12.5
9 influenza, severe 12.0
10 viral pneumonia 11.4
11 haemophilus meningitis 11.3
12 acute necrotizing encephalopathy 11.3
13 encephalopathy, acute, infection-induced 4 11.3
14 epiglottitis 11.2
15 common cold 11.1
16 lung disease 11.1
17 croup 11.1
18 human immunodeficiency virus type 1 11.1
19 acute diarrhea 11.1
20 acquired immunodeficiency syndrome 11.1
21 specific antibody deficiency 10.9
22 complement component 3 deficiency, autosomal recessive 10.8
23 immunodeficiency 39 10.8
24 haverhill fever 10.8
25 gastroenteritis 10.8
26 white matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome 10.8
27 mda5 deficiency 10.8
28 bronchitis 10.6
29 bronchopneumonia 10.5
30 pneumonia 10.5
31 anaerobic pneumonia 10.5
32 tetanus 10.3
33 ornithosis 10.3
34 pertussis 10.3
35 diphtheria 10.3
36 aging 10.3
37 newcastle disease 10.2
38 hepatitis 10.2
39 meningitis 10.2
40 hepatitis b 10.2
41 otitis media 10.1
42 encephalopathy 10.1
43 egg allergy 10.1
44 narcolepsy 10.1
45 vaccinia 10.1
46 myocarditis 10.0
47 respiratory failure 10.0
48 acute disseminated encephalomyelitis 10.0
49 arthritis 10.0
50 leukemia 10.0

Graphical network of the top 20 diseases related to Influenza:



Diseases related to Influenza

Symptoms & Phenotypes for Influenza

Symptoms:

12
  • chills
  • fever
  • sore throat
  • runny nose
  • muscle pains
  • severe headache
  • cough
  • weakness

UMLS symptoms related to Influenza:


symptoms, fever, catarrhal, acute, influenza-like symptoms, snoring, pruritus, fever, coughing

GenomeRNAi Phenotypes related to Influenza according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased influenza A H1N1 (A/Hamburg/04/2009) virus numbers GR00195-A-3 9.13 ISG15 NXF1 XPO1
2 Decreased influenza A H1N1 (A/WSN/33) virus numbers GR00195-A-2 8.8 ISG15 NXF1 XPO1

Drugs & Therapeutics for Influenza

PubMedHealth treatment related to Influenza: 59

Many people turn to home remedies like chicken broth and herbal teas to relieve flu symptoms. And getting plenty to drink is also considered to be important. But there is no scientific proof that any of these things helps speed up recovery. So you don't necessarily need to rely on any of the remedies or to drink more fluids than you feel like.A number of freely available products like vitamin supplements or inhalation devices are marketed for the treatment of colds, flus and coughs. But there is no compelling evidence that they are effective against the flu. Painkillers such as acetaminophen (paracetamol), acetylsalicylic acid (ASA, the drug in medicines like Aspirin) and ibuprofen can relieve pain and lower fever. But children and teenagers should not take ASA because in rare cases this drug can cause a serious brain condition in these age groups.In addition to over-the-counter products, prescription-only medication is also available. The most common of these in Germany is oseltamivir (trade name: Tamiflu). Oseltamivir is prescription-only and needs to be taken within two days after the flu starts. It does not have any effect on the course of the flu infection if you have already had symptoms for longer. Some research suggests that oseltamivir could reduce the period of illness by up to one day. But it often causes nausea and vomiting. It is not clear that it helps to prevent complications. Some people think that antibiotics will help in the treatment of flu. But antibiotics are only effective against bacteria, not against viruses. So antibiotics only help if you have a bacterial infection of the airways as well as a viral infection. Unless there are signs of bacterial infection, there is no point in taking antibiotics.

FDA approved drugs:

# Drug Name Active Ingredient(s) 17 Company Approval Date
1
Tequin 17 Bristol-Myers Squibb December, 1999

Drugs for Influenza (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 819)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 46507594 772
2
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 104987-11-3 445643 439492
3
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
4
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
5
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 24280-93-1 446541
6
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 128794-94-5 5281078
7
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Phase 1 103-90-2 1983
8
Fludarabine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 21679-14-1, 75607-67-9 30751
9
Formaldehyde Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-00-0 712
10
Busulfan Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 55-98-1 2478
11
Ribavirin Approved Phase 4,Phase 3,Phase 2,Phase 1 36791-04-5 37542
12
Histamine Approved, Investigational Phase 4,Phase 3,Phase 1 51-45-6, 75614-87-8 774
13
Phenylephrine Approved Phase 4,Phase 3,Phase 1 59-42-7 6041
14
4-Aminopyridine Approved Phase 4,Phase 2 504-24-5 1727
15
Oxymetazoline Approved, Investigational Phase 4,Phase 3,Phase 1 1491-59-4 4636
16
Ephedrine Approved Phase 4,Phase 3,Phase 1 299-42-3 9294
17
Azelastine Approved Phase 4,Phase 1 58581-89-8 2267
18
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
19
Calcium Carbonate Approved, Investigational Phase 4,Phase 3,Phase 1 471-34-1
20
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2 137-58-6 3676
21
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1 196618-13-0, 204255-11-8 65028
22
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 26787-78-0 33613 2171
23
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 124-94-7 31307
24
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
25
Pseudoephedrine Approved Phase 4,Phase 3,Phase 1 90-82-4 7028
26
Peginterferon alfa-2a Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 198153-51-4 5360545
27
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3 93-14-1 3516
28
Ethanol Approved Phase 4,Phase 2,Phase 1 64-17-5 702
29
Norepinephrine Approved Phase 4 51-41-2 439260
30
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
31
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
32
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 58-22-0 6013
33
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 1 50-28-2 5757
34
Probenecid Approved, Investigational Phase 4,Phase 1 57-66-9 4911
35
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
36
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
37
Ibuprofen Approved Phase 4,Phase 3,Phase 1 15687-27-1 3672
38
Atenolol Approved Phase 4 29122-68-7 2249
39
Clopidogrel Approved Phase 4 120202-66-6, 113665-84-2 60606
40
Acetylcholine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-84-3 187
41
Rasagiline Approved Phase 4 136236-51-6 3052776
42
Fluconazole Approved, Investigational Phase 4,Phase 3,Phase 2 86386-73-4 3365
43
Adalimumab Approved Phase 4,Phase 2 331731-18-1 16219006
44
Ticlopidine Approved Phase 4 55142-85-3 5472
45
Abciximab Approved Phase 4 143653-53-6
46
Azithromycin Approved Phase 4,Phase 2 83905-01-5 53477736 447043 55185
47
Norgestimate Approved, Investigational Phase 4,Phase 1 35189-28-7 6540478
48
Remifentanil Approved Phase 4 132875-61-7 60815
49
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
50
Sulfadiazine Approved, Investigational, Vet_approved Phase 4 68-35-9 5215

Interventional clinical trials:

(show top 50) (show all 3433)

# Name Status NCT ID Phase Drugs
1 The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Unknown status NCT02105519 Phase 4
2 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
3 Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults Unknown status NCT01967368 Phase 4 Intanza;Vaxigrip
4 A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold Unknown status NCT01651663 Phase 4 Arbidol (Umifenovir);Arbidol (Umifenovir)
5 Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults Unknown status NCT01811823 Phase 4
6 High Dose Influenza Vaccine in Nursing Home Unknown status NCT01720277 Phase 4
7 Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. Unknown status NCT01063608 Phase 4
8 Influenza Vaccination in Patients With Scleroderma Unknown status NCT01002508 Phase 4
9 Banlangen Granules Anti-seasonal Influenza Study Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
10 Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines Unknown status NCT01119157 Phase 4
11 Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients Unknown status NCT01512056 Phase 4 AdimFlu-S
12 Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand Unknown status NCT01538940 Phase 4
13 Cell Immunity Response to Vaccination Against Influenza in Patients With Rheumatoid Arthritis Unknown status NCT01002716 Phase 4
14 A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes Unknown status NCT01053377 Phase 4 Tamiflu (verum);Tamiflu placebo
15 VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT) Unknown status NCT02268500 Phase 4
16 Efficacy of Sambucol in the Treatment of Influenza Unknown status NCT00375115 Phase 4 Sambucol
17 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
18 The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A Unknown status NCT01127282 Phase 4 Vitamin (vitamin A 15 mg,C 500 mg, E 400IU);Placebo (digestive tablet)
19 Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease Unknown status NCT02563184 Phase 4
20 Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine Unknown status NCT01980836 Phase 4
21 Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years Unknown status NCT01289535 Phase 4
22 Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients Unknown status NCT01017172 Phase 4
23 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
24 AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) Unknown status NCT02238353 Phase 4 azelastine + fluticasone;Placebo
25 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4 fluticasone/ salmeterol 125/25 mcg/puff;fluticasone/ salmeterol 250/25 mcg/puff
26 Body Composition Measurements in Chronic Heart Failure Unknown status NCT02686866 Phase 4
27 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
28 Corticosteroid Injection Verses High Energy Extracorporeal Shock Wave Therapy for Lateral Epicondylitis Unknown status NCT02613455 Phase 4 Kenalog (triamcinolone);lidocaine 1% (lidocaine HCl 20mg)
29 Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine Unknown status NCT00877357 Phase 4
30 Effectiveness of Trapeziometacarpal Splint Unknown status NCT02635932 Phase 4
31 Efficacy of Dalfampridine on Upper Extremity Function in Patients With MS Unknown status NCT02259361 Phase 4 Sustained-release oral dalfampridine;Placebo
32 Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine Completed NCT02819115 Phase 4
33 Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season Completed NCT03158038 Phase 4
34 Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season Completed NCT02743117 Phase 4
35 Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children Completed NCT02915302 Phase 4
36 Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season Completed NCT02473510 Phase 4
37 Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military Completed NCT02640989 Phase 4
38 Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine Completed NCT02222870 Phase 4
39 The Human Mucosal Immune Responses to Influenza Virus (SLVP026) Completed NCT03023553 Phase 4
40 Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy Children Completed NCT02539108 Phase 4
41 Inactivated Influenza Via Jet Injection Completed NCT02290691 Phase 4
42 A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years Completed NCT02212106 Phase 4
43 Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting Completed NCT01654224 Phase 4
44 Self-Administered Nasal Influenza Feasibility Study Completed NCT01933048 Phase 4 FluMist
45 Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations Completed NCT02908269 Phase 4
46 T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013 Completed NCT03023176 Phase 4
47 B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 Completed NCT02133781 Phase 4
48 B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011) Completed NCT03020498 Phase 4
49 The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine Completed NCT01736709 Phase 4
50 Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine Completed NCT01946425 Phase 4

Search NIH Clinical Center for Influenza

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: influenza, human

Genetic Tests for Influenza

Genetic tests related to Influenza:

# Genetic test Affiliating Genes
1 Influenza 28 IFITM3

Anatomical Context for Influenza

The Foundational Model of Anatomy Ontology organs/tissues related to Influenza:

18
Respiratory Tract

MalaCards organs/tissues related to Influenza:

38
Testes, Lung, Brain, T Cells, Bone, Breast, Heart

Publications for Influenza

Articles related to Influenza:

(show top 50) (show all 4623)
# Title Authors Year
1
Vogt-Koyanagi-Harada Disease Associated with Influenza A Virus Infection: A Case Report. ( 29321438 )
2018
2
Isolation and molecular characterization of an H5N1 swine influenza virus in China in 2015. ( 29164401 )
2018
3
Acute disseminated encephalomyelitis following Influenza A pneumonia. ( 29445493 )
2018
4
Broad-spectrum neutralization of avian influenza viruses by sialylated human milk oligosaccharides: in vivo assessment of 3'-sialyllactose against H9N2 in chickens. ( 29416087 )
2018
5
Identification of high risk areas for avian influenza outbreaks in California using disease distribution models. ( 29385158 )
2018
6
GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis. ( 29138021 )
2018
7
The Application of NHEJ-CRISPR/Cas9 and Cre-Lox System in the Generation of Bivalent Duck Enteritis Virus Vaccine against Avian Influenza Virus. ( 29438322 )
2018
8
Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity. ( 29336924 )
2018
9
Evidence of infection with avian, human, and swine influenza viruses in pigs in Cairo, Egypt. ( 29075888 )
2018
10
Morphea and Extragenital Lichen Sclerosus et Atrophicus After Influenza Vaccination. ( 29025691 )
2018
11
Community health workers on a college campus: Effects on influenza vaccination. ( 29447623 )
2018
12
Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model. ( 29449842 )
2018
13
Characterization of avian influenza H9N2 viruses isolated from ostriches (Struthio camelus). ( 29396439 )
2018
14
The adhesins of non-typeable Haemophilus influenzae. ( 29415569 )
2018
15
Novel Highly Pathogenic Avian Influenza A(H5N6) Virus in the Netherlands, December 2017. ( 29381134 )
2018
16
Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration. ( 29310581 )
2018
17
Relative Vaccine Effectiveness of High-Dose versus Standard-Dose Influenza Vaccines among Veterans Health Administration Patients. ( 29452380 )
2018
18
Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence and birth outcomes; a randomized trial in rural Nepal. ( 29452372 )
2018
19
Haemophilus influenzae-protein D specific antibody correlate with protection against acute otitis media in young children. ( 29395516 )
2018
20
Changing Epidemiology of Haemophilus influenzae in Children. ( 29233576 )
2018
21
Molecular subtyping of European swine influenza viruses and scaling to high-throughput analysis. ( 29316958 )
2018
22
Hemorrhagic encephalitis associated with H3N2 influenza A viral pneumonia. ( 29440541 )
2018
23
Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. ( 29290527 )
2018
24
Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness. ( 29446233 )
2018
25
Maternal Care Providers' Barriers Regarding Influenza and Pertussis Vaccination During Pregnancy in Catalonia, Spain. ( 29417364 )
2018
26
An increasing trend of rural infections of human influenza A (H7N9) from 2013 to 2017: A retrospective analysis of patient exposure histories in Zhejiang province, China. ( 29447278 )
2018
27
Human Infection with Avian Influenza A(H7N2) Virus - Virginia, 2002. ( 29430844 )
2018
28
Global avian influenza outbreaks 2010-2016: a systematic review of their distribution, avian species and virus subtype. ( 29368637 )
2018
29
Maternal Influenza Immunization and Prevention of Severe Clinical Pneumonia in Young Infants: Analysis of Randomized Controlled Trials Conducted in Nepal, Mali, and South Africa. ( 29443825 )
2018
30
Electrostatic Variation of Haemagglutinin as a Hallmark of the Evolution of Avian Influenza Viruses. ( 29386534 )
2018
31
Development and pilot testing of a text message vaccine reminder system for use during an influenza pandemic. ( 29451833 )
2018
32
Antimicrobial activity of a novel bioengineered honey against non-typeable<i>Haemophilus influenzae</i>biofilms: an in vitro study. ( 29449345 )
2018
33
Sudden emergence of human infections with H7N9 avian influenza A virus in Hubei province, central China. ( 29410505 )
2018
34
Safe and effective intradermal influenza vaccine desensitization for delayed influenza vaccine allergy. ( 29448114 )
2018
35
Single nucleotide polymorphisms in genes encoding penicillin-binding proteins in I^-lactamase-negative ampicillin-resistant Haemophilus influenzae in Japan. ( 29352811 )
2018
36
Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015. ( 29449287 )
2018
37
Update: Influenza Activity - United States, October 1, 2017-February 3, 2018. ( 29447145 )
2018
38
Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling. ( 29447284 )
2018
39
Influenza vaccination 2014-2015: Results of a survey conducted among general practitioners in Italy. ( 29451834 )
2018
40
Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults. ( 29434600 )
2018
41
Epilepsy in Children After Pandemic Influenza Vaccination. ( 29449342 )
2018
42
Extreme heterogeneity of influenza virus infection in single cells. ( 29451492 )
2018
43
Aggressive fluid accumulation is associated with acute kidney injury and mortality in a cohort of patients with severe pneumonia caused by influenza A H1N1 virus. ( 29447205 )
2018
44
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. ( 29447141 )
2018
45
Nontypeable Haemophilus influenzae DNA stimulates type I interferon expression via STING signaling pathway. ( 29421524 )
2018
46
Spatial transmission of H5N6 highly pathogenic avian influenza viruses among wild birds in Ibaraki Prefecture, Japan, 2016-2017. ( 29392495 )
2018
47
Convergent Evolution of Human-Isolated H7N9 Avian Influenza A Viruses. ( 29438519 )
2018
48
Local amplification of highly pathogenic avian influenza H5N8 viruses in wild birds in the Netherlands, 2016 to 2017. ( 29382414 )
2018
49
Focal Encephalitis, Meningitis and Acute Respiratory Distress Syndrome Associated with Influenza A Infection. ( 29402867 )
2018
50
Reply to 'Influenza follicles and their buds as early diagnostic markers of influenza: typical images' and demonstration of lymphoid follicles in the posterior pharyngeal walls of patients with mycoplasmal pneumonia. ( 29440479 )
2018